Localized Therapy

SAN ANTONIO, Texas, May 19, 2026 Valion Bio, Inc. has announced a high-level joint engagement with senior officials from...

CARY, N.C. and BRADENTON, Fla., May 20, 2026 Continuity Biosciences has announced the initiation of a Phase I first-in-human...

PEABODY, Mass., Oct. 14, 2025 — Privo Technologies, Inc., a clinical-stage biopharmaceutical company pioneering localized cancer therapies, announced the...